Bill

Bill > HR124


US HR124

US HR124
Byron Nash Renal Medullary Carcinoma Awareness Act of 2023


summary

Introduced
01/09/2023
In Committee
01/20/2023
Crossed Over
Passed
Dead
01/03/2025

Introduced Session

118th Congress

Bill Summary

A BILL To amend title XIX of the Social Security Act to provide incentives for education on the risk of renal medullary carcinoma in individuals who are receiving medical assistance under such title and who have sickle cell disease.

AI Summary

This bill, the Byron Nash Renal Medullary Carcinoma Awareness Act of 2023, aims to amend the Social Security Act to provide incentives for education on the risk of renal medullary carcinoma (a rare and aggressive form of kidney cancer) to individuals with sickle cell disease who are receiving medical assistance under Medicaid. The bill would require Medicaid to cover educational initiatives and resources related to this specific cancer risk for this high-risk population.

Committee Categories

Business and Industry, Health and Social Services

Sponsors (4)

Last Action

Referred to the Subcommittee on Health. (on 01/20/2023)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...